These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
|Status||Trial ID||Title||Completion date||Category|
|Reported results||2015-004257-41||Peanut allergy oral immunoterapy study of AR101 for desensitization in children and adults (the palisade study)||2018-07-02||due-trials|
|Listed as ongoing, but also has a completion date||2016-004941-94||PEANUT ALLERGY ORAL IMMUNOTHERAPY STUDY OF AR101 FOR DESENSITIZATION IN CHILDREN AND ADULTS (PALISADE) FOLLOW-ON STUDY||2019-05-31||bad-data|
|Reported results||2016-005004-26||AR101 TRIAL IN EUROPE MEASURING ORAL IMMUNOTHERAPY SUCCESS IN PEANUT ALLERGIC CHILDREN (ARTEMIS)||2019-02-15||due-trials|
|Ongoing||2017-001334-26||A MULTICENTER, OPEN-LABEL, LONG-TERM SAFETY STUDY OF AR101 CHARACTERIZED ORAL DESENSITIZATION IMMUNOTHERAPY IN SUBJECTS WHO PARTICIPATED IN A PRIOR AR101 STUDY||not-yet-due|
|Listed as ongoing, but also has a completion date||2018-000326-58||Peanut Allergy Oral Immunotherapy Study of AR101 for Desensitization in Children and Adolescents: Real-World, Open-Label, Quality of Life Study||2018-11-23||bad-data|
|Ongoing||2018-001749-15||Peanut Oral Immunotherapy Study of Early Intervention for Desensitization (POSEIDON)||not-yet-due|